Cash flow Hangzhou Tigermed Consulting Co., Ltd

Equities

300347

CNE100001KV8

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. Other stock markets 2026-03-13			5-day change	1st Jan Change
55.11 ^CNY	-1.25%		-3.94%	-2.80%

Mar. 03	Frontage Laboratories, Inc. acquired Teddy Clinical Research Laboratory Co., Ltd from Hangzhou Tigermed Consulting Co., Ltd and Jiaxing Xinge Medical Consulting Co., Ltd.	CI
Mar. 03	Frontage Unit Acquires Research Lab Firm from Tigermed Consulting Unit	MT

8c13088749.CejWmf1JAeBAhVfsLRaZSxSs9S8xLi4hu_oNX5QnzjU.Y7-x0LgGc4ErygaCf070I2P9mxp8f0VL9ohcM8Zri2BviabWvDxUmHPpHg

Published financial data: HANGZHOU TIGERMED CONSULTING CO., LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	3.18B	5.19B	7B	7.29B	6.47B
Other Revenues, Total	16.04M	26.17M	83.93M	94.93M	129M
Total Revenues	3.19B	5.21B	7.09B	7.38B	6.6B
Cost of Goods Sold, Total	1.68B	2.94B	4.28B	4.54B	4.36B
Gross Profit	1.51B	2.27B	2.81B	2.85B	2.24B
Selling General & Admin Expenses, Total	487M	677M	780M	838M	944M
Provision for Bad Debts	-11.97M	25.72M	23.86M	36.68M	29.73M
R&D Expenses	157M	212M	235M	262M	238M
Other Operating Expenses	3.67M	12.5M	7.57M	19.15M	22.2M
Other Operating Expenses, Total	636M	927M	1.05B	1.15B	1.23B
Operating Income	879M	1.34B	1.76B	1.69B	1.01B
Interest Expense, Total	-50.78M	-24.91M	-83.18M	-120M	-141M
Interest And Investment Income	394M	568M	330M	568M	257M
Net Interest Expenses	343M	543M	247M	448M	116M
Currency Exchange Gains (Loss)	-147M	-11.83M	20.13M	2.61M	18.02M
Other Non Operating Income (Expenses)	-2.48M	-1.48M	-6.88M	-3.32M	-6.59M
EBT, Excl. Unusual Items	1.07B	1.87B	2.02B	2.14B	1.14B
Impairment of Goodwill	-	-	-	-29.16M	-5M
Gain (Loss) On Sale Of Investments	1.14B	1.82B	536M	353M	-502M
Gain (Loss) On Sale Of Assets	-886K	-531K	-86.63K	-188K	3.56M
Asset Writedown	-	-	-445K	-	-
Other Unusual Items	9.2M	-3.96M	27.5M	27.24M	31.05M
EBT, Incl. Unusual Items	2.22B	3.68B	2.59B	2.49B	664M
Income Tax Expense	190M	293M	314M	339M	217M
Earnings From Continuing Operations	2.03B	3.39B	2.27B	2.15B	448M
Net Income to Company	2.03B	3.39B	2.27B	2.15B	448M
Minority Interest	-279M	-518M	-265M	-125M	-42.69M
Net Income - (IS)	1.75B	2.87B	2.01B	2.02B	405M
Net Income to Common Incl Extra Items	1.75B	2.87B	2.01B	2.02B	405M
Net Income to Common Excl. Extra Items	1.75B	2.87B	2.01B	2.02B	405M
Per Share Items
Net EPS - Basic	2.2	3.31	2.32	2.34	0.47
Basic EPS - Continuing Operations	2.2	3.31	2.32	2.34	0.47
Basic Weighted Average Shares Outstanding	795M	868M	865M	865M	863M
Net EPS - Diluted	2.19	3.3	2.32	2.34	0.47
Diluted EPS - Continuing Operations	2.19	3.3	2.32	2.34	0.47
Diluted Weighted Average Shares Outstanding	799M	871M	865M	865M	863M
Normalized Basic EPS	0.49	0.75	1.15	1.4	0.77
Normalized Diluted EPS	0.49	0.75	1.15	1.4	0.77
Dividend Per Share	0.3	0.5	0.55	0.57	0.3
Payout Ratio	15.5	9.89	24.52	29.13	158.5
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	959M	1.46B	1.92B	1.88B	1.21B
EBITA	905M	1.38B	1.83B	1.76B	1.1B
EBIT	879M	1.34B	1.76B	1.69B	1.01B
EBITDAR	959M	1.46B	1.92B	1.88B	1.23B
Total Revenues (As Reported)	3.19B	5.21B	7.09B	7.38B	6.6B
Effective Tax Rate - (Ratio)	8.55	7.95	12.13	13.61	32.6
Total Current Taxes	125M	269M	332M	-	241M
Total Deferred Taxes	64.38M	24.14M	-18.14M	-	-24.05M
Normalized Net Income	391M	654M	999M	1.21B	668M
Interest on Long-Term Debt	-	21.24M	25.33M	27.92M	25.96M
Supplemental Operating Expense Items
Advertising Expense	10.98M	14.45M	19.24M	19.97M	14.1M
Selling and Marketing Expenses	96.58M	129M	150M	187M	208M
General and Administrative Expenses	391M	547M	630M	650M	737M
Research And Development Expense From Footnotes	157M	212M	235M	262M	238M
Net Rental Expense, Total	130K	130K	545K	1.12M	14.94M
Imputed Operating Lease Interest Expense	78.47K	39.8K	197K	356K	5.46M
Imputed Operating Lease Depreciation	51.86K	90.53K	349K	769K	9.48M
Stock-Based Comp., G&A Exp. (Total)	31.42M	83.24M	46.64M	20.23M	45.44M
Stock-Based Comp., Other (Total)	8.76M	9.04M	7.87M	-	61.42M
Total Stock-Based Compensation	40.19M	92.28M	54.51M	20.23M	107M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	10.12B	8.54B	7.86B	7.42B	2.06B
Short Term Investments	-	-	-	40.99M	14.67M
Trading Asset Securities, Total	26M	29.18M	24.95M	42.14M	74.85M
Total Cash And Short Term Investments	10.15B	8.57B	7.88B	7.5B	2.14B
Accounts Receivable, Total	1.32B	2.1B	3.03B	3.63B	3.87B
Other Receivables	115M	75.85M	92.26M	109M	125M
Total Receivables	1.44B	2.18B	3.12B	3.73B	4B
Inventory	4.72M	6.1M	22.2M	23.4M	31.96M
Prepaid Expenses	1M	815K	1.07M	1.73M	4.99M
Other Current Assets, Total	55.19M	93.97M	77.5M	81.52M	122M
Total Current Assets	11.65B	10.85B	11.11B	11.34B	6.3B
Gross Property Plant And Equipment	1.08B	1.63B	2.05B	2.41B	2.81B
Accumulated Depreciation	-401M	-504M	-721M	-937M	-1.13B
Net Property Plant And Equipment	683M	1.12B	1.33B	1.47B	1.69B
Long-term Investments	5.37B	9.5B	11.8B	13.22B	13.54B
Goodwill	1.44B	1.78B	2.49B	2.76B	3.23B
Other Intangibles, Total	142M	251M	338M	371M	337M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	79.51M	101M	121M	135M	127M
Deferred Charges Long-Term	33.43M	35.2M	211M	214M	210M
Other Long-Term Assets, Total	110M	102M	62.56M	157M	3.25B
Total Assets	19.51B	23.74B	27.45B	29.68B	28.67B
Liabilities
Accounts Payable, Total	101M	148M	158M	249M	257M
Accrued Expenses, Total	183M	351M	404M	443M	335M
Short-term Borrowings	-	492M	1.85B	1.97B	1.91B
Current Portion of Long-Term Debt	-	-	19.56M	397M	80.18M
Current Portion of Leases	52.29M	74.52M	118M	123M	118M
Current Income Taxes Payable	72.86M	176M	85.87M	124M	53.41M
Unearned Revenue Current, Total	485M	790M	940M	680M	791M
Other Current Liabilities	246M	381M	156M	153M	115M
Total Current Liabilities	1.14B	2.41B	3.73B	4.14B	3.66B
Long-Term Debt	-	-	245M	434M	324M
Long-Term Leases	279M	407M	489M	423M	399M
Unearned Revenue Non Current	-	-	14.79M	14.59M	17.14M
Deferred Tax Liability Non Current	132M	202M	214M	214M	202M
Other Non Current Liabilities	97.49M	115M	73.12M	2.54M	2.78M
Total Liabilities	1.65B	3.14B	4.77B	5.23B	4.61B
Common Stock, Total	872M	872M	872M	872M	865M
Additional Paid In Capital	12B	11.89B	11.85B	11.71B	10.77B
Retained Earnings	3.48B	6.09B	7.66B	9.21B	9.13B
Treasury Stock	-136M	-568M	-869M	-869M	-191M
Comprehensive Income and Other	-92.01M	-156M	65.55M	104M	99.1M
Total Common Equity	16.12B	18.12B	19.58B	21.03B	20.67B
Minority Interest	1.74B	2.48B	3.1B	3.43B	3.39B
Total Equity	17.86B	20.61B	22.68B	24.45B	24.06B
Total Liabilities And Equity	19.51B	23.74B	27.45B	29.68B	28.67B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	872M	866M	866M	865M	861M
ECS Total Common Shares Outstanding	872M	869M	869M	865M	861M
Book Value / Share	18.47	20.86	22.55	24.31	24
Tangible Book Value	14.53B	16.09B	16.76B	17.89B	17.11B
Tangible Book Value Per Share	16.66	18.52	19.3	20.68	19.86
Total Debt	331M	974M	2.72B	3.35B	2.83B
Net Debt	-9.82B	-7.6B	-5.16B	-4.16B	689M
Debt Equivalent Oper. Leases	1.04M	1.04M	4.36M	9M	120M
Minority Interest, Total (Incl. Fin. Div)	1.74B	2.48B	3.1B	3.43B	3.39B
Equity Method Investments, Total	60.27M	739M	1.8B	2.98B	3.42B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	4.72M	6.1M	22.2M	26.57M	32.89M
Buildings, Total	139M	151M	244M	288M	451M
Machinery, Total	470M	655M	817M	959M	1.1B
Full Time Employees	6.03K	8.33K	9.23K	9.7K	10.18K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	41.35M	52.46M	77.53M	119M	152M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.75B	2.87B	2.01B	2.02B	405M
Depreciation & Amortization - CF	118M	149M	200M	232M	235M
Amortization of Goodwill and Intangible Assets - (CF)	26.65M	40.3M	64.61M	74.18M	88.79M
Depreciation & Amortization, Total	145M	189M	265M	306M	324M
Amortization of Deferred Charges, Total - (CF)	5.51M	7.84M	20.1M	33.34M	39.9M
(Gain) Loss From Sale Of Asset	886K	531K	86.63K	188K	-3.56M
(Gain) Loss on Sale of Investments - (CF)	-1.42B	-2.13B	-639M	-691M	335M
Asset Writedown & Restructuring Costs	-	-	445K	29.16M	5M
Stock-Based Compensation (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	-11.97M	25.72M	23.86M	36.68M	29.73M
Other Operating Activities, Total	479M	553M	329M	245M	165M
Change In Accounts Receivable	-142M	-809M	-869M	-719M	-1.02B
Change In Inventories	-3.52M	-1.37M	-16.11M	-4.36M	3.66M
Change In Accounts Payable	105M	575M	194M	-112M	752M
Change In Deferred Taxes	56.61M	44.12M	-7.56M	-13.85M	-6.76M
Change in Other Net Operating Assets	36.8M	92.26M	50.52M	16.09M	64.89M
Cash from Operations	999M	1.42B	1.36B	1.15B	1.1B
Capital Expenditure	-156M	-369M	-449M	-314M	-357M
Sale of Property, Plant, and Equipment	694K	1.43M	2.02M	5.31M	2.34M
Cash Acquisitions	-194M	-318M	-663M	-351M	-363M
Divestitures	4.84M	67.1M	-	-	-
Investment in Marketable and Equity Securities, Total	-1.87B	-2.14B	-1.78B	-973M	-4.09B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-8.95M
Other Investing Activities, Total	-156M	-24.45M	99.7M	98.19M	74.26M
Cash from Investing	-2.37B	-2.78B	-2.79B	-1.53B	-4.74B
Long-Term Debt Issued, Total	1.19B	492M	3.44B	3.2B	3.38B
Total Debt Issued	1.19B	492M	3.44B	3.2B	3.38B
Long-Term Debt Repaid, Total	-2.09B	-	-1.95B	-2.67B	-4.03B
Total Debt Repaid	-2.09B	-	-1.95B	-2.67B	-4.03B
Issuance of Common Stock	11.21B	272M	339M	396M	133M
Repurchase of Common Stock	-	-	-427M	-29.85M	-271M
Common Dividends Paid	-271M	-284M	-492M	-590M	-642M
Common & Preferred Stock Dividends Paid	-271M	-284M	-492M	-590M	-642M
Other Financing Activities, Total	-698M	-643M	-99.85M	-319M	-270M
Cash from Financing	9.34B	-163M	809M	-7.81M	-1.7B
Foreign Exchange Rate Adjustments	-47.48M	-59.56M	26.93M	8.79M	-6.92M
Net Change in Cash	7.92B	-1.58B	-596M	-383M	-5.35B
Supplemental Items
Cash Income Tax Paid (Refund)	241M	322M	595M	645M	524M
Levered Free Cash Flow	474M	721M	-108M	316M	245M
Unlevered Free Cash Flow	506M	737M	-55.94M	391M	333M
Change In Net Working Capital	77.12M	23.36M	1.05B	711M	412M
Net Debt Issued / Repaid	-903M	492M	1.49B	535M	-653M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	4.06	3.88	4.3	3.7	2.16
Return on Total Capital	4.44	4.22	4.69	3.97	2.31
Return On Equity %	17.36	17.64	10.5	9.12	1.85
Return on Common Equity	17.2	16.79	10.64	9.97	1.94
Margin Analysis
Gross Profit Margin %	47.43	43.55	39.64	38.53	33.99
SG&A Margin	15.26	12.98	11.01	11.34	14.3
EBITDA Margin %	30.03	27.97	27.11	25.4	18.4
EBITA Margin %	28.36	26.55	25.78	23.9	16.63
EBIT Margin %	27.52	25.77	24.87	22.89	15.29
Income From Continuing Operations Margin %	63.56	65.06	32.06	29.12	6.78
Net Income Margin %	54.81	55.13	28.32	27.42	6.14
Net Avail. For Common Margin %	54.81	55.13	28.32	27.42	6.14
Normalized Net Income Margin	12.25	12.53	14.1	16.4	10.11
Levered Free Cash Flow Margin	14.86	13.84	-1.52	4.28	3.71
Unlevered Free Cash Flow Margin	15.85	14.13	-0.79	5.3	5.05
Asset Turnover
Asset Turnover	0.24	0.24	0.28	0.26	0.23
Fixed Assets Turnover	5.76	5.77	5.79	5.28	4.18
Receivables Turnover (Average Receivables)	2.56	3.03	2.73	2.19	1.73
Inventory Turnover (Average Inventory)	566.25	544.16	302.27	199.06	157.49
Short Term Liquidity
Current Ratio	10.22	4.5	2.98	2.74	1.72
Quick Ratio	10.17	4.46	2.95	2.72	1.68
Operating Cash Flow to Current Liabilities	0.88	0.59	0.36	0.28	0.3
Days Sales Outstanding (Average Receivables)	143.13	120.39	133.79	166.66	211.88
Days Outstanding Inventory (Average Inventory)	0.65	0.67	1.21	1.83	2.32
Average Days Payable Outstanding	19.21	15.44	13	16.37	21.23
Cash Conversion Cycle (Average Days)	124.57	105.61	121.99	152.12	192.98
Long Term Solvency
Total Debt/Equity	1.86	4.73	11.99	13.69	11.77
Total Debt / Total Capital	1.82	4.51	10.71	12.04	10.53
LT Debt/Equity	1.56	1.97	3.23	3.51	3
Long-Term Debt / Total Capital	1.53	1.89	2.89	3.08	2.69
Total Liabilities / Total Assets	8.45	13.21	17.36	17.61	16.07
EBIT / Interest Expense	17.3	53.94	21.19	14.1	7.15
EBITDA / Interest Expense	20.15	61.53	24.37	16.65	9.44
(EBITDA - Capex) / Interest Expense	17.07	46.73	18.98	14.03	6.92
Total Debt / EBITDA	0.32	0.64	1.34	1.68	2.12
Net Debt / EBITDA	-9.59	-4.96	-2.55	-2.08	0.52
Total Debt / (EBITDA - Capex)	0.38	0.84	1.72	1.99	2.9
Net Debt / (EBITDA - Capex)	-11.33	-6.53	-3.27	-2.47	0.7
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	13.88	63.32	35.91	4.21	-10.58
Gross Profit, 1 Yr. Growth %	16.22	49.95	23.69	1.31	-21.13
EBITDA, 1 Yr. Growth %	26.72	52.14	31.72	-2.39	-35.23
EBITA, 1 Yr. Growth %	25.92	52.88	32.01	-3.43	-37.76
EBIT, 1 Yr. Growth %	23.2	52.93	31.16	-4.1	-40.28
Earnings From Cont. Operations, 1 Yr. Growth %	108.03	67.16	-33.02	-5.36	-79.17
Net Income, 1 Yr. Growth %	107.9	64.26	-30.19	0.91	-79.99
Normalized Net Income, 1 Yr. Growth %	-7.28	67.1	52.86	21.21	-44.87
Diluted EPS Before Extra, 1 Yr. Growth %	93.81	50.68	-29.7	0.86	-79.94
Accounts Receivable, 1 Yr. Growth %	13.45	59.16	44.23	19.6	6.76
Inventory, 1 Yr. Growth %	291.61	29.1	264.3	5.37	36.58
Net Property, Plant and Equip., 1 Yr. Growth %	60.32	64.56	18.04	11.05	14.51
Total Assets, 1 Yr. Growth %	158.95	21.71	15.61	8.14	-3.4
Tangible Book Value, 1 Yr. Growth %	389.11	10.75	4.14	6.75	-4.39
Common Equity, 1 Yr. Growth %	281.46	12.44	8.05	7.37	-1.69
Cash From Operations, 1 Yr. Growth %	89.3	42.57	-4.66	-15.25	-4.64
Capital Expenditures, 1 Yr. Growth %	52.07	135.54	21.7	-30.06	13.64
Levered Free Cash Flow, 1 Yr. Growth %	31.35	54.96	-115.15	-373.59	-22.49
Unlevered Free Cash Flow, 1 Yr. Growth %	30.98	48.2	-107.69	-715.25	-14.77
Dividend Per Share, 1 Yr. Growth %	7.91	66.67	10	3.27	-47.18
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	17.79	36.37	48.98	19.01	-3.46
Gross Profit, 2 Yr. CAGR %	23.57	32.01	36.19	11.94	-10.61
EBITDA, 2 Yr. CAGR %	30.14	38.85	41.57	13.4	-20.49
EBITA, 2 Yr. CAGR %	32.86	38.74	42.06	12.92	-22.48
EBIT, 2 Yr. CAGR %	31.54	37.26	41.62	12.16	-24.33
Earnings From Cont. Operations, 2 Yr. CAGR %	100.09	86.48	5.81	-20.38	-55.6
Net Income, 2 Yr. CAGR %	92.5	84.8	7.09	-16.07	-55.07
Normalized Net Income, 2 Yr. CAGR %	5.34	24.47	59.82	36.13	-18.26
Diluted EPS Before Extra, 2 Yr. CAGR %	86.45	70.89	2.93	-15.79	-55.02
Accounts Receivable, 2 Yr. CAGR %	29.97	34.38	51.51	31.34	13
Inventory, 2 Yr. CAGR %	201.64	124.85	116.87	95.93	19.97
Net Property, Plant and Equip., 2 Yr. CAGR %	63.66	62.43	39.37	14.49	12.77
Total Assets, 2 Yr. CAGR %	113.49	77.53	18.62	11.81	2.21
Tangible Book Value, 2 Yr. CAGR %	200.64	132.74	7.39	5.44	1.03
Common Equity, 2 Yr. CAGR %	145.77	107.1	10.22	7.71	2.74
Cash From Operations, 2 Yr. CAGR %	38.29	64.28	16.59	-10.11	-10.11
Capital Expenditures, 2 Yr. CAGR %	30.62	89.26	69.31	-7.74	-10.85
Levered Free Cash Flow, 2 Yr. CAGR %	39.1	41.35	-51.85	-33.38	45.62
Unlevered Free Cash Flow, 2 Yr. CAGR %	40.26	38.11	-66.46	-26.7	128.99
Dividend Per Share, 2 Yr. CAGR %	13.4	34.11	35.4	6.58	-26.15
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	23.69	31.35	36.22	32.25	8.19
Gross Profit, 3 Yr. CAGR %	27.86	31.8	29.18	23.4	-0.39
EBITDA, 3 Yr. CAGR %	31.67	37.09	36.43	25.07	-5.91
EBITA, 3 Yr. CAGR %	31.96	39.22	36.46	24.92	-7.42
EBIT, 3 Yr. CAGR %	31.16	38.31	35.2	24.37	-9.09
Earnings From Cont. Operations, 3 Yr. CAGR %	82.8	88.45	32.56	1.95	-49.08
Net Income, 3 Yr. CAGR %	79.8	82.59	33.59	4.99	-47.96
Normalized Net Income, 3 Yr. CAGR %	16.51	22.85	33.29	45.76	0.72
Diluted EPS Before Extra, 3 Yr. CAGR %	75.28	73.67	27.1	2.23	-47.8
Accounts Receivable, 3 Yr. CAGR %	27.86	39.05	37.58	40.03	22.58
Inventory, 3 Yr. CAGR %	595.57	127.32	164.09	70.49	73.72
Net Property, Plant and Equip., 3 Yr. CAGR %	50.08	63.96	46.03	29.21	14.5
Total Assets, 3 Yr. CAGR %	75.91	77.02	53.88	15.02	6.49
Tangible Book Value, 3 Yr. CAGR %	116.84	115.51	78.01	7.18	2.05
Common Equity, 3 Yr. CAGR %	86.34	89.37	66.73	9.27	4.48
Cash From Operations, 3 Yr. CAGR %	46.91	39.7	37.03	4.83	-8.32
Capital Expenditures, 3 Yr. CAGR %	50.44	58.99	63.36	26.09	-1.1
Levered Free Cash Flow, 3 Yr. CAGR %	22.44	43.31	-33.14	-12.1	-29.93
Unlevered Free Cash Flow, 3 Yr. CAGR %	23.96	42.03	-47.49	-7.69	-22.92
Dividend Per Share, 3 Yr. CAGR %	31.05	28.93	25.54	23.71	-15.66
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	27.24	34.73	33.24	26.27	18.69
Gross Profit, 5 Yr. CAGR %	29.1	38.43	31.13	23.47	11.49
EBITDA, 5 Yr. CAGR %	31.51	48.2	35.54	27.07	9.93
EBITA, 5 Yr. CAGR %	33.32	51.76	35.91	28.03	8.84
EBIT, 5 Yr. CAGR %	32.86	51.47	35.25	27.19	7.2
Earnings From Cont. Operations, 5 Yr. CAGR %	63.46	84.94	46.89	33.51	-14.42
Net Income, 5 Yr. CAGR %	62.11	82.84	46.14	33.8	-13.6
Normalized Net Income, 5 Yr. CAGR %	26.31	41.98	32.21	28	9.62
Diluted EPS Before Extra, 5 Yr. CAGR %	55.61	75.18	41.66	30.01	-16.11
Accounts Receivable, 5 Yr. CAGR %	28.16	36.28	36.84	35.91	27.17
Inventory, 5 Yr. CAGR %	60.94	152.08	336.4	114.2	92.61
Net Property, Plant and Equip., 5 Yr. CAGR %	28.61	41.18	45.7	42.02	31.69
Total Assets, 5 Yr. CAGR %	64.69	58.3	50.26	47.3	30.65
Tangible Book Value, 5 Yr. CAGR %	94.72	73.92	63.71	61.91	41.92
Common Equity, 5 Yr. CAGR %	74.29	61.95	51.04	51.11	37.37
Cash From Operations, 5 Yr. CAGR %	39.99	49.3	33.94	17.11	15.77
Capital Expenditures, 5 Yr. CAGR %	12.44	42.99	57.72	27.89	28.21
Levered Free Cash Flow, 5 Yr. CAGR %	47.3	98.18	-16.02	5.22	-7.46
Unlevered Free Cash Flow, 5 Yr. CAGR %	48.16	90.61	-26.77	8.74	-2.91
Dividend Per Share, 5 Yr. CAGR %	35.08	49.61	32.77	19.48	1.53